🇺🇸 FDA
Pipeline program

SPN-810M

810P111

Phase 1 small_molecule completed

Quick answer

SPN-810M for Impulsive Aggression Comorbid With ADHD is a Phase 1 program (small_molecule) at SUPERNUS PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
SUPERNUS PHARMACEUTICALS, INC.
Indication
Impulsive Aggression Comorbid With ADHD
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials